Pre-eclampsia and gestational hypertension are less common in HIV infected women

被引:32
作者
Hall, David [1 ,2 ]
Gebhardt, Stefan [1 ,2 ,3 ]
Theron, Gerhard [1 ,2 ]
Grove, Debbie [1 ,2 ]
机构
[1] Univ Stellenbosch, Dept Obstet & Gynecol, ZA-7505 Tygerberg, South Africa
[2] Tygerberg Hosp, ZA-7505 Tygerberg, South Africa
[3] Paarl Hosp, Dept Obstet & Gynecol, Boland, South Africa
关键词
HIV; AIDS; Pre-eclampsia; Hypertension; Pregnancy; HAART; ACTIVE ANTIRETROVIRAL THERAPY; INCREASED RISK; MANAGEMENT; PREGNANCY; DISORDERS; DEATH;
D O I
10.1016/j.preghy.2013.11.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether pre-eclampsia and gestational hypertension are less common in HIV infected women. Methods: This prospective cohort study was performed in the Western Cape province of South Africa. HIV negative and positive pregnant women without chronic renal or chronic hypertensive disease were continuously recruited. During the study period HIV positive patients received either mono-or triple (HAART) antiretroviral therapy for prevention of vertical transmission or maternal care. Only routine clinical management was performed. The development of hypertensive disease during pregnancy was recorded. Results: 1093 HIV positive and 1173 HIV negative cases were identified during pregnancy and evaluated again after delivery. Significantly fewer cases of pre-eclampsia n = 35 (3.2%) were recorded in the HIV positive group than in the HIV negative group, n = 57 (4.9%) (p = 0.045; OR 0.65 95% CI 0.42-0.99). There were also significantly fewer cases of gestational hypertension recorded in the HIV positive group compared to the HIV negative group (p = 0.026; OR 0.53 95% CI 0.30-0.94). Multiple logistic regression analysis confirmed the reductive effect of HIV on pre-eclampsia and gestational hypertension. Conclusion: Pre-eclampsia and gestational hypertension are less common in HIV infected women being managed with mono-or triple anti-retroviral therapy. (C) 2013 International Society for the Study of Hypertension in Pregnancy Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 25 条
[1]   The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery [J].
Boer, K. ;
Nellen, J. F. ;
Patel, D. ;
Timmermans, S. ;
Tempelman, C. ;
Wibaut, M. ;
Sluman, M. A. ;
van der Ende, M. E. ;
Godfried, M. H. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (02) :148-155
[2]   Risk of Preeclampsia in HIV-Positive Pregnant Women Receiving HAART: A Matched Cohort Study [J].
Boyajian, Talar ;
Shah, Prakesh S. ;
Murphy, Kellie E. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2012, 34 (02) :136-141
[3]   The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) [J].
Brown, MA ;
Lindheimer, MD ;
de Swiet, M ;
Van Assche, A ;
Moutquin, JM .
HYPERTENSION IN PREGNANCY, 2001, 20 (01) :IX-XIV
[4]   Maternal infection and risk of preeclampsia: Systematic review and metaanalysis [J].
Conde-Agudelo, Agustin ;
Villar, Jose ;
Lindheimer, Marshall .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (01) :7-22
[5]   Characteristics of hypertensive disorders in twin versus singleton pregnancies [J].
Foo, J. Y. ;
Mangos, G. J. ;
Brown, M. A. .
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2013, 3 (01) :3-9
[6]   Does human immunodeficiency virus infection protect against preeclampsia-eclampsia? [J].
Frank, KA ;
Buchmann, EJ ;
Schackis, RC .
OBSTETRICS AND GYNECOLOGY, 2004, 104 (02) :238-242
[7]   Is pre-eclampsia less common in patients with HIV/AIDS? [J].
Hall, David R. .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2007, 76 (1-2) :75-77
[8]   Early pre-eclampsia:: What proportion of women qualify for expectant management and if not, why not? [J].
Hall, David R. ;
Grove, Debbie ;
Carstens, Erna .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 128 (1-2) :169-174
[9]   Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants-but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis [J].
Huusom, L. D. ;
Secher, N. J. ;
Pryds, O. ;
Whitfield, K. ;
Gluud, C. ;
Brok, J. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 118 (01) :1-5
[10]  
Kalumba VMS, 2012, S AFR J OG, V18, P59